ID2 and Alzheimer disease: Taken together, the results show that Id2 functions as a negative regulator of TGFβ/Smad in neuroblastoma cells and activation of the TGFβ pathway is at least partially responsible for the transition of AD cells to an AI phenotype (Figure 8).